Another of the top peer-reviewed journals serving radiology is experiencing a time of peak influence.

To subspecialize or not to subspecialize? That’s a crucial question for radiology trainees who are finishing their residency but have yet to settle on a lifelong career path.

A medical imaging OEM has been cleared to market MRI image reconstruction software that, according to the company, sacrifices nothing in image quality despite allowing patients to be scanned up to three times faster than conventional methods. 

The shortage of iodinated contrast media that has rattled U.S. radiology since early May didn’t come from nowhere.

Fewer than 40% of rural counties in the U.S. can offer residents any access to point-of-care ultrasound, while nearly 90% of their metropolitan counterparts have POCUS aplenty. 

Editor David Bluemke, MD, PhD, says the journal’s rising impact factor is “representative of the fundamental importance of imaging throughout our hospitals and clinics.”

“More than most companies, Toyota is led from the bottom up as much as from the top down.”

A cancer-care technology company that was acquired by one of the world’s largest imaging OEMs a year ago has received an Investigational Device Exemption from the FDA.